Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,298Revenue $M1,373Net Margin (%)-6.1Z-Score1.4
Enterprise Value $M2,823EPS $-0.6Operating Margin %-4.9F-Score4
P/E(ttm))0Cash Flow Per Share $1.5Pre-tax Margin (%)-6.9Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %0Quick Ratio1.1Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %-11.0Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow7.5y-y EBITDA Growth Rate %107ROA % (ttm)-3.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)12ROE % (ttm)-6.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M180ROI % (ttm)-3.5Gross Margin Increase y-yY

Gurus Latest Trades with MDRX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDRXThird Avenue Management 2014-12-31 Reduce-0.37%$11.23 - $13.855
($12.71)
$ 12.750%Reduce -68.1%615,859
MDRXVanguard Health Care Fund 2014-09-30 Add0.09%$13.4 - $16.81
($15.14)
$ 12.75-16%Add 30.96%11,187,763
MDRXLee Ainslie 2014-06-30 Sold Out -1.3%$14.44 - $18.29
($15.58)
$ 12.75-18%Sold Out0
MDRXLee Ainslie 2014-03-31 Buy 1.3%$14.71 - $19.43
($17.23)
$ 12.75-26%New holding, 5255290 sh.5,255,290
MDRXJoel Greenblatt 2013-12-31 Sold Out -0.01%$13.83 - $15.38
($14.72)
$ 12.75-13%Sold Out0
MDRXThird Avenue Management 2013-09-30 Add0.07%$13.12 - $16.26
($15.11)
$ 12.75-16%Add 22.02%1,380,244
MDRXJoel Greenblatt 2013-09-30 Reduce$13.12 - $16.26
($15.11)
$ 12.75-16%Reduce -20.82%17,732
MDRXVanguard Health Care Fund 2013-06-30 Add0.21%$12.58 - $14.09
($13.4)
$ 12.75-5%Add 108.41%8,351,463
MDRXJoel Greenblatt 2013-06-30 Reduce-0.01%$12.58 - $14.09
($13.4)
$ 12.75-5%Reduce -43.45%22,394
MDRXThird Avenue Management 2012-12-31 Buy 0.25%$9.08 - $13.9
($12.13)
$ 12.755%New holding, 1235495 sh.1,235,495
MDRXVanguard Health Care Fund 2012-12-31 Add0.03%$9.08 - $13.9
($12.13)
$ 12.755%Add 55.24%3,787,009
MDRXJoel Greenblatt 2012-12-31 Reduce-0.03%$9.08 - $13.9
($12.13)
$ 12.755%Reduce -44.58%45,460
MDRXJoel Greenblatt 2012-09-30 Reduce-0.03%$8.99 - $12.42
($10.42)
$ 12.7522%Reduce -31.85%82,022
MDRXMichael Price 2012-06-30 Buy 0.63%$9.41 - $16.69
($12.31)
$ 12.754%New holding, 400000 sh.400,000
MDRXVanguard Health Care Fund 2012-06-30 Buy 0.13%$9.41 - $16.69
($12.31)
$ 12.754%New holding, 2439400 sh.2,439,400
MDRXJoel Greenblatt 2012-06-30 Add0.08%$9.41 - $16.69
($12.31)
$ 12.754%Add 442.49%120,363
MDRXRon Baron 2012-06-30 Sold Out -0.13%$9.41 - $16.69
($12.31)
$ 12.754%Sold Out0
MDRXJoel Greenblatt 2012-03-31 Buy 0.03%$16.68 - $21.47
($17.78)
$ 12.75-28%New holding, 22187 sh.22,187
MDRXRon Baron 2012-03-31 Reduce-0.04%$16.68 - $21.47
($17.78)
$ 12.75-28%Reduce -20.47%1,305,220
MDRXGeorge Soros 2011-06-30 Sold Out $18.48 - $22.71
($20.21)
$ 12.75-37%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MDRX Vanguard Health Care Fund 2014-12-3111,198,8936.210.34+0.1%
MDRX Michael Price 2014-12-31477,5000.260.74
MDRX Third Avenue Management 2014-12-31615,8590.340.2-68.1%
Premium Most recent portfolio changes are included for Premium Members only!


MDRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Black PaulCEO and President 2014-12-12Buy6,500$11.519.47view
HEWITT JAMESSVP Development 2014-11-19Buy900$12.213.19view
Pramoda AnitaDirector 2014-11-18Buy2,017$12.252.86view
CHOOKASZIAN DENNISDirector 2014-11-13Buy10,000$12.431.37view
Farley BrianSVP Gerneral Counsel & Corpora 2014-11-12Buy852$11.727.51view
THURMAN RANDY HDirector 2014-11-11Buy8,849$11.2911.6view
Black PaulCEO and President 2014-11-11Buy22,180$11.2611.9view
STEVENS DAVID DDirector 2014-11-11Buy8,845$11.2811.7view
Poulton Richard J.CFO 2014-11-11Buy4,500$11.2611.9view
Cindrich Robert JDirector 2014-11-11Buy4,430$11.2811.7view

Press Releases about MDRX :

    Quarterly/Annual Reports about MDRX:

    News about MDRX:

    Articles On GuruFocus.com
    Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
    Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
    American Insider Trades: March 8-15 Mar 15 2013 
    The Barclays Triggers More Insider Buying Mar 13 2013 
    Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
    Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 
    Larry Robbins Grows in Tenet Healthcare Shares Oct 24 2012 
    Weekly Guru Bargains Highlights: ANR, CHK, MDRX, APAGF, CLWR Apr 30 2012 
    5 'Very Cheap' Buy Ideas Mar 04 2012 
    Weekly CFO Sells Highlight: MDRX, JDSU, CAVM, S, SPW Feb 26 2011 


    More From Other Websites
    Home Care by Black Stone to Leverage Allscripts Feb 19 2015
    Allscripts Sunrise EHR: IHMC's Choice for Flagship Hospital - Analyst Blog Feb 13 2015
    International Hospital Management Corporation Chooses Allscripts Sunrise Feb 11 2015
    Thermo Fisher's Q4 Gains on Life Technologies Integration - Analyst Blog Feb 11 2015
    Cerner Q4 Earnings & Revenues Beat Estimates, Up Y/Y - Analyst Blog Feb 11 2015
    International Hospital Management Corporation Chooses Allscripts Sunrise Feb 11 2015
    Merge, ICT Health Tie Up for Imaging Solutions in IMEA Region - Analyst Blog Feb 10 2015
    CVS Health Earnings in Line, Revenues Beat Estimates in Q4 - Analyst Blog Feb 10 2015
    Omnicell Posts Solid Q4, Positive on 3-Legged Strategies - Analyst Blog Feb 10 2015
    athenahealth Tops Q4 Earnings & Revenues; '15 View Revised - Analyst Blog Feb 06 2015
    Springhill Medical Center Achieves HIMSS EMRAM Stage 7 Feb 05 2015
    Springhill Medical Center Achieves HIMSS EMRAM Stage 7 Feb 05 2015
    Springhill Medical Center Achieves HIMSS EMRAM Stage 7 Feb 05 2015
    Omnicell Tops Q4 Earnings, Revenues on 3-Legged Strategy - Analyst Blog Feb 04 2015
    Sunrise(TM) by Allscripts Wins Best in KLAS Award Jan 30 2015
    Sunrise(TM) by Allscripts Wins Best in KLAS Award Jan 30 2015
    Sunrise(TM) by Allscripts Wins Best in KLAS Award Jan 30 2015
    ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 26 2015
    Quality Systems (QSII) in Focus: Stock Jumps 6.5% - Tale of the Tape Jan 23 2015
    Ex-Brocade CEO Michael Klayko takes over as CEO at AOptix Jan 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK